US Stock MarketDetailed Quotes

ANEB Anebulo Pharmaceuticals

Watchlist
  • 1.640
  • +0.020+1.24%
Close Jan 7 16:00 ET
67.38MMarket Cap-5.47P/E (TTM)

Anebulo Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-14.82%2.17M
-29.49%8.31M
-46.26%1.34M
-41.89%1.66M
-27.61%2.76M
-2.62%2.54M
72.50%11.78M
7.26%2.49M
52.37%2.86M
255.99%3.81M
Selling and administrative expenses
-13.84%1.1M
-23.02%4.76M
-18.99%872.66K
-48.39%915.91K
-12.63%1.7M
-8.27%1.27M
59.79%6.18M
-10.78%1.08M
84.04%1.77M
126.43%1.94M
-General and administrative expense
-13.84%1.1M
-23.02%4.76M
-18.99%872.66K
-48.39%915.91K
-12.63%1.7M
-8.27%1.27M
59.79%6.18M
-10.78%1.08M
84.04%1.77M
126.43%1.94M
Research and development costs
3.51%1.31M
-36.63%3.55M
-67.00%467.71K
-31.30%748.34K
-43.17%1.06M
3.80%1.27M
89.10%5.6M
26.74%1.42M
19.01%1.09M
778.16%1.87M
Other operating expenses
---245.36K
----
----
----
----
----
----
----
----
----
Operating profit
14.82%-2.17M
29.49%-8.31M
46.26%-1.34M
41.89%-1.66M
27.61%-2.76M
2.62%-2.54M
-72.50%-11.78M
-7.26%-2.49M
-52.37%-2.86M
-255.99%-3.81M
Net non-operating interest income expense
-161.04%-33.69K
5.83%97.79K
-158,066.67%-9.48K
-89.40%8.39K
395.51%43.68K
55.2K
1,160.32%92.41K
6
79.15K
8.82K
Non-operating interest income
-52.89%26.01K
169.48%249.02K
836,866.67%50.22K
-13.98%68.08K
756.65%75.52K
--55.2K
1,160.32%92.41K
--6
--79.15K
--8.82K
Non-operating interest expense
--59.7K
--151.23K
--59.7K
--59.7K
--31.84K
--0
--0
--0
--0
--0
Other net income (expense)
-103.70%-283
122.51%9.26K
89.64%-124
117.74%2.32K
97.38%-594
3,511.79%7.66K
-2,215.48%-41.15K
73.92%-1.2K
-514.91%-13.08K
-1,111.66%-22.65K
Other non- operating income (expenses)
-103.70%-283
122.51%9.26K
89.64%-124
117.74%2.32K
97.38%-594
3,511.79%7.66K
-2,215.48%-41.15K
73.92%-1.2K
-514.91%-13.08K
-1,111.66%-22.65K
Income before tax
11.29%-2.2M
30.09%-8.2M
45.91%-1.35M
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
-256.66%-3.83M
Income tax
Net income
11.29%-2.2M
30.09%-8.2M
45.91%-1.35M
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
-256.66%-3.83M
Net income continuous Operations
11.29%-2.2M
30.09%-8.2M
45.91%-1.35M
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
-256.66%-3.83M
Minority interest income
Net income attributable to the parent company
11.29%-2.2M
30.09%-8.2M
45.91%-1.35M
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
-256.66%-3.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
11.29%-2.2M
30.09%-8.2M
45.91%-1.35M
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
-256.66%-3.83M
Basic earnings per share
20.00%-0.08
31.91%-0.32
50.00%-0.05
45.45%-0.06
26.67%-0.11
9.09%-0.1
-62.07%-0.47
0.00%-0.1
-37.50%-0.11
-200.00%-0.15
Diluted earnings per share
20.00%-0.08
31.91%-0.32
50.00%-0.05
45.45%-0.06
26.67%-0.11
9.09%-0.1
-62.07%-0.47
0.00%-0.1
-37.50%-0.11
-200.00%-0.15
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Sep 30, 2024 (FY)Jun 30, 2024 (Q4)Jun 30, 2024 (Q3)Mar 31, 2024 (Q2)Dec 31, 2023 (Q1)Sep 30, 2023 (FY)Jun 30, 2023 (Q4)Jun 30, 2023 (Q3)Mar 31, 2023 (Q2)Dec 31, 2022
Total revenue 0 0 0 0 0 0 0 0 0 0
Operating revenue --0 --0 --0 --0 --0 --0 --0 --0 --0 --0
Cost of revenue
Gross profit
Operating expense -14.82%2.17M -29.49%8.31M -46.26%1.34M -41.89%1.66M -27.61%2.76M -2.62%2.54M 72.50%11.78M 7.26%2.49M 52.37%2.86M 255.99%3.81M
Selling and administrative expenses -13.84%1.1M -23.02%4.76M -18.99%872.66K -48.39%915.91K -12.63%1.7M -8.27%1.27M 59.79%6.18M -10.78%1.08M 84.04%1.77M 126.43%1.94M
-General and administrative expense -13.84%1.1M -23.02%4.76M -18.99%872.66K -48.39%915.91K -12.63%1.7M -8.27%1.27M 59.79%6.18M -10.78%1.08M 84.04%1.77M 126.43%1.94M
Research and development costs 3.51%1.31M -36.63%3.55M -67.00%467.71K -31.30%748.34K -43.17%1.06M 3.80%1.27M 89.10%5.6M 26.74%1.42M 19.01%1.09M 778.16%1.87M
Other operating expenses ---245.36K ---- ---- ---- ---- ---- ---- ---- ---- ----
Operating profit 14.82%-2.17M 29.49%-8.31M 46.26%-1.34M 41.89%-1.66M 27.61%-2.76M 2.62%-2.54M -72.50%-11.78M -7.26%-2.49M -52.37%-2.86M -255.99%-3.81M
Net non-operating interest income expense -161.04%-33.69K 5.83%97.79K -158,066.67%-9.48K -89.40%8.39K 395.51%43.68K 55.2K 1,160.32%92.41K 6 79.15K 8.82K
Non-operating interest income -52.89%26.01K 169.48%249.02K 836,866.67%50.22K -13.98%68.08K 756.65%75.52K --55.2K 1,160.32%92.41K --6 --79.15K --8.82K
Non-operating interest expense --59.7K --151.23K --59.7K --59.7K --31.84K --0 --0 --0 --0 --0
Other net income (expense) -103.70%-283 122.51%9.26K 89.64%-124 117.74%2.32K 97.38%-594 3,511.79%7.66K -2,215.48%-41.15K 73.92%-1.2K -514.91%-13.08K -1,111.66%-22.65K
Other non- operating income (expenses) -103.70%-283 122.51%9.26K 89.64%-124 117.74%2.32K 97.38%-594 3,511.79%7.66K -2,215.48%-41.15K 73.92%-1.2K -514.91%-13.08K -1,111.66%-22.65K
Income before tax 11.29%-2.2M 30.09%-8.2M 45.91%-1.35M 40.90%-1.65M 28.99%-2.72M 5.02%-2.48M -71.89%-11.73M -7.44%-2.5M -49.11%-2.8M -256.66%-3.83M
Income tax
Net income 11.29%-2.2M 30.09%-8.2M 45.91%-1.35M 40.90%-1.65M 28.99%-2.72M 5.02%-2.48M -71.89%-11.73M -7.44%-2.5M -49.11%-2.8M -256.66%-3.83M
Net income continuous Operations 11.29%-2.2M 30.09%-8.2M 45.91%-1.35M 40.90%-1.65M 28.99%-2.72M 5.02%-2.48M -71.89%-11.73M -7.44%-2.5M -49.11%-2.8M -256.66%-3.83M
Minority interest income
Net income attributable to the parent company 11.29%-2.2M 30.09%-8.2M 45.91%-1.35M 40.90%-1.65M 28.99%-2.72M 5.02%-2.48M -71.89%-11.73M -7.44%-2.5M -49.11%-2.8M -256.66%-3.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 11.29%-2.2M 30.09%-8.2M 45.91%-1.35M 40.90%-1.65M 28.99%-2.72M 5.02%-2.48M -71.89%-11.73M -7.44%-2.5M -49.11%-2.8M -256.66%-3.83M
Basic earnings per share 20.00%-0.08 31.91%-0.32 50.00%-0.05 45.45%-0.06 26.67%-0.11 9.09%-0.1 -62.07%-0.47 0.00%-0.1 -37.50%-0.11 -200.00%-0.15
Diluted earnings per share 20.00%-0.08 31.91%-0.32 50.00%-0.05 45.45%-0.06 26.67%-0.11 9.09%-0.1 -62.07%-0.47 0.00%-0.1 -37.50%-0.11 -200.00%-0.15
Dividend per share
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- Unqualified Opinion -- -- -- -- Unqualified Opinion -- -- --
Heat List
US
Overall
Symbol
Price
% Chg

No Data